Mode
Text Size
Log in / Sign up
N/A N=200 Treatment

Determinants of Smoking Cessation Among Latinos

Smoking Cessation

Enrolled (actual)
200
Serious AEs
0.0%
Results posted
Mar 2020
Primary outcome: Primary: Number of Participants With 24-Hour Smoking Abstinence (Week 3 Post Quit Day) — 100 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Nicotine Replacement Therapy (NRT) (Drug); Questionnaire (Behavioral); Counseling (Behavioral); Self-Help Materials (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
M.D. Anderson Cancer Center
Primary completion
Sep 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With 24-Hour Smoking Abstinence (Week 3 Post Quit Day)
100
PRIMARY
24-Hour Smoking Abstinence (Week 26 Post Quit Day)
41
PRIMARY
7-Day Smoking Abstinence (Week 3 Post Quit Day)
76
PRIMARY
7-Day Smoking Abstinence (Week 26 Post Quit Day)
33
PRIMARY
30-Day Smoking Abstinence (Week 26 Post Quit Day)
28
PRIMARY
7-Day Smoking Abstinence (Week 3 Post Quit Day) Intent to Treat
57
PRIMARY
7-Day Smoking Abstinence (Week 26 Post Quit Day) Intent to Treat
20
PRIMARY
7-Day Smoking Abstinence (Week 3 Post Quit Day) Continuous Abstinence
57
PRIMARY
7-Day Smoking Abstinence (Week 26 Post Quit Day) Continuous Abstinence
20

Summary

The goal of this study is to learn how neighborhood and individual factors affect the ability to stop smoking among Spanish-speaking Mexican American (MA) smokers who want to quit smoking.

Eligibility Criteria

Inclusion Criteria

  • Current daily smoker who average >/= 5 cigarettes/day for the last year
  • Mexican-American (MA) Adults from the Houston-based MA Cohort Study and/or from the community
  • Age 18 to 65 years
  • Motivated to quit smoking in the next 30 days
  • Viable (working) telephone number and home address
  • Prefers to speak in Spanish
  • Register "8" or more on a carbon monoxide breath test

Exclusion Criteria

  • Contraindication for nicotine patch use
  • Regular use of tobacco products other than cigarettes (cigars, pipes, smokeless tobacco)
  • Use of nicotine replacement therapy products or other smoking cessation medications, other than the nicotine patches supplied during the study
  • Pregnancy or lactation
  • Currently enrolled in a smoking cessation program
  • Participation in a smoking cessation program or study during the past 90 days
  • Another household member is enrolled in this protocol
  • Active substance abuse problem
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01008748). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search